SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Wang Xiaoliang)
 

Sökning: WFRF:(Wang Xiaoliang) > TIMP1 is a prognost...

  • Song, GuoheDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)

TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway

  • Artikel/kapitelEngelska2016

Förlag, utgivningsår, omfång ...

  • 2016-09-20
  • London, United Kingdom :BioMed Central (BMC),2016
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-52526
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-52526URI
  • https://doi.org/10.1186/s13046-016-0427-7DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agency:National Nature Science Foundation of China 81472241  81270557
  • Background: Tissue inhibitor matrix metalloproteinase 1 (TIMP1) plays a vital role in carcinogenesis, yet its precise functional roles and regulation remain unclear. In this study, we aim to investigate its biological function and clinical significance in human colon cancer.Methods: We analyzed the expression of TIMP1 in both public database (Oncomine and TCGA) and 94 cases of primary colon cancer and matched normal colon tissue specimens. The underlying mechanisms of altered TIMP1 expression on cell tumorigenesis, proliferation, and metastasis were explored in vitro and in vivo.Results: TIMP1 was overexpressed in colon tumorous tissues and lymph node metastasis specimens than in normal tissues. The aberrant expression of TIMP1 was significantly associated with the regional lymph node metastasis (p = 0.033), distant metastasis (p = 0.039), vascular invasion (p = 0.024) and the American Joint Committee on Cancer (AJCC) stage (p = 0.026). Cox proportional hazards model showed that TIMP1 was an independent prognostic indicator of disease-free survival (HR = 2.603, 95 % CI: 1.115-6.077, p = 0.027) and overall survival (HR = 2.907, 95 % CI: 1.254-6.737, p = 0.013) for patients with colon cancer. Consistent with this, our findings highlight that suppression of TIMP1 expression decreased proliferation, and metastasis but increased apoptosis by inducing TIMP1 specific regulated FAK-PI3K/AKT and MAPK pathway.Conclusion: TIMP1 might play an important role in promoting tumorigenesis and metastasis of human colon cancer and function as a potential prognostic indicator for colon cancer.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Xu, ShifengDepartment of General Surgery, Shandong Provincial Hospital, Shandong University, Jinan, People’s Republic of China (författare)
  • Zhang, Hong,1957-Örebro universitet,Institutionen för medicinska vetenskaper(Swepub:oru)hzg (författare)
  • Wang, YupengDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Xiao, ChaoDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Jiang, TaoDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Wu, LeileiSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Zhang, TaoDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Sun, XingDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Zhong, LinDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Zhou, ChongzhiDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Wang, ZhaowenDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Peng, ZhihaiDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Chen, JianDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Wang, XiaoliangDepartment of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China (författare)
  • Department of General Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of ChinaDepartment of General Surgery, Shandong Provincial Hospital, Shandong University, Jinan, People’s Republic of China (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of Experimental & Clinical Cancer ResearchLondon, United Kingdom : BioMed Central (BMC)35:11756-9966

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy